Lyxor UCITS Valuation
| MTIX Etf | 13,730 25.00 0.18% |
Based on Macroaxis valuation methodology, the etf is overvalued. Lyxor UCITS EuroMTS secures a last-minute Real Value of USD13455.89 per share. The latest price of the etf is USD13730.5. Our model forecasts the value of Lyxor UCITS EuroMTS from analyzing the etf technical indicators and probability of bankruptcy. In general, investors recommend acquiring undervalued etfs and selling overvalued etfs since, at some point, etf prices and their ongoing real values will merge together.
Overvalued
Today
Please note that Lyxor UCITS's price fluctuation is very steady at this time. Calculation of the real value of Lyxor UCITS EuroMTS is based on 3 months time horizon. Increasing Lyxor UCITS's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Lyxor etf is determined by what a typical buyer is willing to pay for full or partial control of Lyxor UCITS EuroMTS. Since Lyxor UCITS is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Lyxor Etf. However, Lyxor UCITS's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 13730.5 | Real 13455.89 | Hype 13730.5 | Naive 13810.28 |
The intrinsic value of Lyxor UCITS's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Lyxor UCITS's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Lyxor UCITS EuroMTS helps investors to forecast how Lyxor etf's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Lyxor UCITS more accurately as focusing exclusively on Lyxor UCITS's fundamentals will not take into account other important factors: About Lyxor UCITS Valuation
The etf valuation mechanism determines Lyxor UCITS's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Lyxor UCITS EuroMTS based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Lyxor UCITS. We calculate exposure to Lyxor UCITS's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Lyxor UCITS's related companies.Other Information on Investing in Lyxor Etf
Lyxor UCITS financial ratios help investors to determine whether Lyxor Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Lyxor with respect to the benefits of owning Lyxor UCITS security.